Search Clinical Trials
 
By Condition
 
By Location (USA)
 
By Location (Other)
 
By Sponsor
 
Resources
 
Privacy Policy
 
About Us
Disclaimer
Curcumin for the Prevention of Colon Cancer Clinical Trials Information presented on Clinical Trials Search isn't designed to be a substitute for certified healthcare advice, travels to or professional assistance using a genuine medical doctor. We are not physicians. Always confer with your dr. about Curcumin for the Prevention of Colon Cancer conditions. Clinical Trials Search.org is a site devoted to listing clinical research studies in human subjects. Curcumin for the Prevention of Colon Cancer Clinical research trials and Curcumin for the Prevention of Colon Cancer medical trials happen in hundreds of places across the United States. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials usually measure the effectualness of new drugs. The intention of the studies / undertakings is to solve certain human healthcare questions. Clinical trials are a popular manner for mDs, government agencies, and private sector companies to locate treatments for all forms of circumstances, such as Curcumin for the Prevention of Colon Cancer. Curcumin for the Prevention of Colon Cancer Clinical Trials and other clinical trials allow for volunteers to undergo medical treatment choices before they are available to the general public. Some times the human subjects get treatment for free of charge, and sometimes they are paid for their time. Occasionally there is a cost for a Curcumin for the Prevention of Colon Cancer clinical trial. Participants frequently get the best healthcare available for their Curcumin for the Prevention of Colon Cancer condition. Risks are a reality, nonetheless, and can include extra or frequent physician trips, medical risks (possibly life-jeopardising), and/or the treatment being ineffective. Trials are federally governed with exacting guidelines to protect clinical trials subjects.

Home > "C" Clinical Trials Conditions > Curcumin for the Prevention of Colon Cancer

Curcumin for the Prevention of Colon Cancer



Curcumin for the Prevention of Colon Cancer

For Condition: Colon Cancer
Status: Recruiting
Sponsor(s): University of Michigan Comprehensive Cancer Center , National Cancer Institute (NCI)
Synopsis: RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the development of cancer. Curcumin may be effective in preventing the development of colon cancer. PURPOSE: Phase I trial to determine the dose amount of curcumin that can be tolerated to help in preventing colon cancer in healthy men and women.
Details: OBJECTIVES: - Determine the maximum tolerated dose (MTD) of curcumin as a chemopreventive agent of colon cancer in healthy subjects. - Determine if tolerable doses of this agent in uniformly milled formulation capsules are bioavailable in these subjects. - Determine the pharmacokinetics of this agent and two metabolites at the MTD and next lower escalated dose in these subjects. OUTLINE: This is a dose escalation study followed by a pharmacokinetic study. Patients receive a single oral dose of curcumin followed by a standard fatty meal. Cohorts of 3-6 patients receive escalating doses of curcumin until the maximum tolerated dose (MTD) is determined. The MTD is defined as the dose at which 2 of 6 patients experience dose limiting toxicities. Once the MTD is determined, additional patients are accrued to receive curcumin in the pharmacokinetic phase of the study. Patients are followed at 24, 36, 48, and 72 hours. PROJECTED ACCRUAL: A total of 3-24 patients will be accrued for the dose escalation phase and then 12 additional patients will be accrued for the pharmacokinetic phase of this study within 3 months.
Eligibility:
Study Type:  Interventional, Prevention
Minimum Age/Maximum Age: 18 Years/
Genders: Both
Protocol Entry Criteria: DISEASE CHARACTERISTICS: - Healthy men and women age 18 and over PATIENT CHARACTERISTICS: Age: - 18 and over Performance status: - Not specified Life expectancy: - Not specified Hematopoietic: - WBC greater than 4,000/mm3 - Hemoglobin greater than 12 g/dL - Platelet count greater than 120,000/mm3 Hepatic: - ALT/AST less than 1.5 times upper limit of normal (ULN) - Alkaline phosphatase less than 1.5 times ULN - Bilirubin less than 1.5 mg/dL Renal: - Creatinine less than 1.7 mg/dL Other: - Not pregnant or nursing - Negative pregnancy test - Fertile patients must use effective contraception - No prior cancer except surgically resected basal cell or squamous cell skin cancer - No history of peptic ulcer disease, gastrointestinal bleeding from gastric or duodenal ulcers, or gastrin secreting tumors - No history of unreliability or noncompliance (missing pretreatment appointment more than twice) PRIOR CONCURRENT THERAPY: Biologic therapy: - Not specified Chemotherapy: - Not specified Endocrine therapy: - At least 14 days since prior steroids Radiotherapy: - Not specified Surgery: - Not specified Other: - At least 14 days since prior curcumin (turmeric) rich foods - At least 14 days since prior nonsteroidal antiinflammatory drugs (NSAIDs) - No chronic medications (i.e., daily for more than 28 days) except for oral contraceptives - No concurrent coumadin or other anticoagulants
Total Enrollment: 

Location and Contact Information:

Overall Study Official:
DeanBrenner,  Study Chair,  University of Michigan Comprehensive Cancer Center

University of Michigan Comprehensive Cancer Center *Recruiting*
Ann Arbor,  Michigan,  48109-0930
United States
Recruiting Dean  Brenner 734-647-1417


Additional Information:
Study ID Numbers:  CDR0000067916;  UMN-9941,NCI-P00-0144,CCUM-9941
Study Start Date: 
Record last reviewed: January 2002
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00027495

Other Colon Cancer Studies:
1. Irinotecan and Capecitabine in Treating Patients With Solid Tumors

2. Celecoxib With or Without Eflornithine in Preventing Colorectal Cancer in Patients With Familial Adenomatous Polyposis.

3. Combination Chemotherapy in Treating Patients With Liver Metastases from Colorectal Cancer

4. Combination Chemotherapy in Treating Patients With Unresectable Liver Metastases from Colorectal Cancer

5. Hepatic Arterial Infusion Plus Chemotherapy in Treating Patients With Colorectal Cancer Metastatic to the Liver

Related Studies:

Other Colon Cancer Clinical Trials
Other Michigan Clinical Trials
Other Ann Arbor Clinical Trials

Curcumin for the Prevention of Colon Cancer
Modify your Search

  Other Colon Cancer Clinical Trials
  Other Michigan Clinical Trials
  Other Ann Arbor Clinical Trials


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103